PRQR peer analysis
PRQR (PRQR) against its competitors: price, today's move, 1-year return and market value side by side.
- PRQR's peers: ACHV (Achieve Life Sciences), ALLO (Allogene Therapeutics), ARCT (Arcturus), CAPR (Capricor), EDIT (Editas Medicine), IMMP (Immutep), MREO (Mereo BioPharma), TRDA (Entrada Therapeutics).
PRQR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACHV Achieve Life Sciences | $6.78 | 0.89% | 47.71% | $697.68M |
| ALLO Allogene Therapeutics | $0.63 | -4.83% | -49.63% | $219.90M |
| ARCT Arcturus | $7.55 | -0.66% | 25.00% | $217.61M |
| CAPR Capricor | $1.65 | -78.15% | -70.83% | $95.27M |
| EDIT Editas Medicine | $1.66 | -2.92% | -34.13% | $256.20M |
| IMMP Immutep | $3.42 | 5.23% | -90.45% | $25.20M |
| MREO Mereo BioPharma | $0.28 | -4.94% | -84.81% | $219.59M |
| TRDA Entrada Therapeutics | $4.20 | -9.48% | -51.89% | $164.43M |
| VNDA Vanda Pharmaceuticals | $3.46 | -5.72% | -32.68% | $209.23M |
| ZURA Zura Bio | $0.93 | -2.34% | -75.97% | $89.59M |
| PRQR ProQR Therapeutics | $1.04 | -0.95% | -48.77% | $146.77M |